Content about Inhaler

January 31, 2012
Homeopathic asthma care

As of Jan. 1, asthma products like the Primatine Mist inhaler became no longer available at retail — leaving consumers with few asthma-care options in the OTC aisle. Drug Store News recently interviewed King Bio president Frank King, who is introducing a new nonprescription inhaler for asthmatics, formulated with homeopathic ingredients, called AsthmaCare under its Safecare banner of products.

AUDIO Q&A: DSN interviewed Frank King, King Bio president, who is introducing a new nonprescription inhaler for asthmatics, formulated with homeopathic ingredients, called AsthmaCare under its Safecare banner of products. As of Jan. 1, asthma products like the Primatine Mist inhaler became unavailable at retail — leaving consumers with few asthma care options in the OTC aisle.

May 10, 2013
FDA approves Breo Ellipta for COPD

The Food and Drug Administration has approved a new treatment for chronic obstructive pulmonary disease, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for chronic obstructive pulmonary disease, the agency said Friday.

The FDA announced the approval of Breo Ellipta (fluticasone furoate and vilanterol), a once-per-day inhaler made by GlaxoSmithKline and Theravance for long-term treatment of COPD, which includes chronic bronchitis and emphysema.

May 1, 2013
Teva introduces generic bronchospasm drug

Teva Pharmaceutical Industries has launched a generic inhaler used to treat bronchospasm, the company said.

NORTH WALES, Pa. — Teva Pharmaceutical Industries has launched a generic inhaler used to treat bronchospasm, the company said.

Teva announced the introduction of levalbuterol inhalation solution. The product is a generic version of Sunovion's Xopenex and is available in the 0.31 mg, 0.63 mg and 1.25 mg strengths.

Various versions of the drug had sales of $438.8 million in 2012, according to IMS Health.

April 22, 2013
Allermates launching EpiPen, Auvi-Q and asthma inhaler carrying cases

Allermates today announced it is introducing EpiPen, Auvi-Q and asthma inhaler carrying cases.

NANUET, N.Y. — Allermates today announced it is introducing EpiPen, Auvi-Q and asthma inhaler carrying cases.

The cases come in colorful kid-friendly designs and include AllerMates characters. Each case comes with an emergency contact and medication information card. The EpiPen carrying case is insulated, and comes with an epinephrine auto-injector user guide. The cases, like all AllerMates products, are nickel-, lead-, latex-, BPA- and phthalate-free.

April 17, 2013
FDA panel gives favorable vote to GSK, Theravance COPD drug

A Food and Drug Administration panel has recommended that the agency approve an experimental drug for chronic obstructive pulmonary disease made by GlaxoSmithKline and Theravance, the two companies said.

LONDON — A Food and Drug Administration panel has recommended that the agency approve an experimental drug for chronic obstructive pulmonary disease made by GlaxoSmithKline and Theravance, the two companies said.

The FDA Pulmonary-Allergy Drugs Advisory Committee voted 9-4 to recommend Breo Ellipta as a long-term maintenance treatment for airflow obstruction in patients with COPD and for reduction of COPD exacerbations in patients with a history of them. The drug is a once-daily inhaler that combines fluticasone furoate and vilanterol.

January 3, 2013
Teva announces inhaler with dose counter for bronchospasm

An inhaler for patients with bronchospasm that includes a dose counter has become available from Teva Respiratory, the company said Thursday.

NORTH WALES, Pa. — An inhaler for patients with bronchospasm that includes a dose counter has become available from Teva Respiratory, the company said Thursday.

The company, which is the branded respiratory division of Israeli drug maker Teva Pharmaceutical Industries, announced the available of ProAir HFA (i.e., albuterol sulfate), for patients aged 4 and older to prevent and treat bronchospasm with reversible obstructive airway disease and prevent exercise-induced bronchospasm. The inhaler received Food and Drug Administration approval in March 2012.

December 10, 2012
Giant-Carlisle participates in GSK inhaler recycling program

Several stores in the Giant Food Stores chain will collect used respiratory inhalers under a program sponsored by drug maker GlaxoSmithKline, the supermarket chain said.

CARLISLE, Pa. — Several stores in the Giant Food Stores chain will collect used respiratory inhalers under a program sponsored by drug maker GlaxoSmithKline, the supermarket chain said.

Giant, an Ahold-owned banner also known as Giant-Carlisle to distinguish it from fellow Ahold banner Giant Food of Landover, Md., said 48 stores in Pennsylvania would participate in GSK's "Complete the Cycle" recycle program for respiratory inhalers used to treat asthma, chronic obstructive pulmonary disease, allergies and flu.

October 24, 2012
GSK rolls out inhaler-recycling program

Several cities across the country will play host to a new program from one drug maker to recycle respiratory inhalers.

RESEARCH TRIANGLE PARK, N.C. — Several cities across the country will play host to a new program from one drug maker to recycle respiratory inhalers.

Calling it the first program of its kind in the pharmaceutical industry, GlaxoSmithKline announced Wednesday the Complete the Cycle program, which it announced last month and for which it is currently enrolling pharmacies. Inhalers usually go to landfills because they can't be recycled by curbside recyclers.

September 12, 2012
GSK launches inhaler recycling program

GlaxoSmithKline is offering a recycling program for empty inhalers at retail pharmacies in 31 cities, the drug maker said Wednesday.

NEW YORK — GlaxoSmithKline is offering a recycling program for empty inhalers at retail pharmacies in 31 cities, the drug maker said Wednesday.

The company announced its "Complete the Cycle" program for GSK respiratory inhalers, starting in October.

June 21, 2012
Breath of relief

Homeopathic supplier King Bio currently is presenting a replacement alternative for patients still seeking relief for their minor asthma symptoms in its 
AsthmaCare product.


NEW YORK — Homeopathic supplier King Bio currently is presenting a replacement alternative for patients still seeking relief for their minor asthma symptoms in its 
AsthmaCare product.


June 21, 2012
COPD spurs drug development

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention.

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention. And combined, the two diseases cause more than 100,000 deaths per year. Fortunately, however, there is a wide range of treatments available for both, many of which work for both diseases.


March 20, 2012
Novartis launches Arcapta Neohaler

Novartis has launched a new treatment for chronic obstructive pulmonary disease, the drug maker said Monday.

EAST HANOVER, N.J. — Novartis has launched a new treatment for chronic obstructive pulmonary disease, the drug maker said Monday.

Novartis Pharmaceuticals, the U.S. division of the Swiss drug manufacturer, announced the launch of Arcapta Neohaler (indacaterol inhalation powder) in the 75-mcg strength. The Food and Drug Administration approved the drug last July.

March 12, 2012
Ascent Consumer to spice up nasal saline sets with dry salt inhaler launch

Melville, N.Y.-based Ascent Consumer Products late last month introduced a new delivery form to the nasal saline category — a dry salt inhaler branded InHalo — as a new solution to help break up mucous and promote nasal and bronchial drainage at the ECRM Cough & Cold and Allergy EPPS conference held here.

LAS VEGAS — Melville, N.Y.-based Ascent Consumer Products late last month introduced a new delivery form to the nasal saline category — a dry salt inhaler branded InHalo — as a new solution to help break up mucous and promote nasal and bronchial drainage at the ECRM Cough & Cold and Allergy EPPS conference held here.

March 9, 2012
FDA approves Teva inhaler with dose counter

The Food and Drug Administration has approved a version of a drug made by Teva that includes a dose counter, the drug maker said.

NORTH WALES, Pa. — The Food and Drug Administration has approved a version of a drug made by Teva that includes a dose counter, the drug maker said.

Teva announced the approval of the inhaled drug ProAir HFA (albuterol sulfate) with a dose counter for treating bronchospasm with reversible obstructive airway disease and preventing exercise-induced bronchospasm in patients ages 4 years and older. The dose counter is designed to help patients and caregivers keep track of the number of doses in the canister.

February 21, 2012
Schumer calls on FDA to investigate inhaler product marketed as supplement

Sen. Charles Schumer on Tuesday announced that the Food and Drug Administration has agreed to conduct a full review of the safety and legality of the new caffeine inhaler AeroShot, distributed by Breathable Foods, which hit stores in New York and Boston this past month.

WASHINGTON — Sen. Charles Schumer on Tuesday announced that the Food and Drug Administration has agreed to conduct a full review of the safety and legality of the new caffeine inhaler AeroShot, distributed by Breathable Foods, which hit stores in New York and Boston this past month.

February 17, 2012
Breathing OTC life into asthma

Asthma has been becoming more relevant in the nonprescription aisles of late.

Asthma has been becoming more relevant in the nonprescription aisles of late. Even as Armstrong Pharmaceuticals phases out what was an almost $100 million-and-growing brand in Primatene Mist 
— the Food and Drug Administration has removed any inhalers containing 
chlorofluorocarbons from the market — homeopathic supplier King Bio is currently presenting an alternative in its AsthmaCare product.


February 17, 2012
COPD pipeline grows 
despite patent cliff

One of the main plotlines of the big story called the drug industry over the past several years has been the patent cliff, the steady loss of patent protection on blockbuster primary care drugs and subsequent generic competition that has forced many drug companies to find new revenue streams.

One of the main plotlines of the big story called the drug industry over the past several years has been the patent cliff, the steady loss of patent protection on blockbuster primary care drugs and subsequent generic competition that has forced many drug companies to find new revenue streams. Much of this has taken place in the form of a gradual shift to specialty drugs for such conditions as cancers and autoimmune disorders, but recent developments have shown that primary care drugs may still have some steam left in them.


November 9, 2011
Mylan acquires rights to Pfizer's inhaler technology

Generic drug maker Mylan has bought rights to a drug delivery platform made by Pfizer that will allow it to make generic versions of two GlaxoSmithKline respiratory drugs, Mylan said Wednesday.

PITTSBURGH — Generic drug maker Mylan has bought rights to a drug delivery platform made by Pfizer that will allow it to make generic versions of two GlaxoSmithKline respiratory drugs, Mylan said Wednesday.

October 10, 2011
FDA approves Boehringer Ingelheim COPD treatment

The Food and Drug Administration has approved a new product for chronic obstructive pulmonary disease made by Boehringer Ingelheim Pharmaceuticals, the drug maker said.

RIDGEFIELD, Conn. — The Food and Drug Administration has approved a new product for chronic obstructive pulmonary disease made by Boehringer Ingelheim Pharmaceuticals, the drug maker said.

September 22, 2011
OTC asthma inhalers phased out by year end

Epinephrine inhalers will not be made or sold after Dec. 31, and patients using them should get new prescriptions to replace them, the Food and Drug Administration said Thursday.

SILVER SPRING, Md. — Epinephrine inhalers will not be made or sold after Dec. 31, and patients using them should get new prescriptions to replace them, the Food and Drug Administration said Thursday.

Epinephrine inhalers, which Armstrong Pharmaceutical markets under the brand name Primatene Mist, are used to relieve symptoms of mild asthma and are sold over-the-counter.

April 19, 2011
InhalerWear introduces pediatric asthma compliance tool

InhalerWear on Tuesday announced its launch of a neoprene cover for inhalers that will help make carrying around an inhaler “trendy and cool” to children and teenagers. The new inhaler can be clipped to a backpack, purse or belt loop.

BOSTON — InhalerWear on Tuesday announced its launch of a neoprene cover for inhalers that will help make carrying around an inhaler “trendy and cool” to children and teenagers. The new inhaler can be clipped to a backpack, purse or belt loop.

"We started InhalerWear because we knew the challenge facing parents was not in getting their kids to use their inhaler, but to get them to carry their inhalers with them at all times,” stated co-founder Rob Fiore.

March 16, 2011
Asthma relief soon to revert to Rx-only indication

The Food and Drug Administration on Wednesday announced that the only over-the-counter asthma inhaler sold in the United States no longer will be available as of Dec. 31 as part of an international agreement to stop the use of substances that damage the environment.

SILVER SPRING, Md. — The Food and Drug Administration on Wednesday announced that the only over-the-counter asthma inhaler sold in the United States no longer will be available as of Dec. 31 as part of an international agreement to stop the use of substances that damage the environment.

March 8, 2011
HealthOneMed debuts Dispense-a-Pill

HealthOneMed has launched a device that combines the abilities of pillboxes, reminders, dispensers and medication alerts into one.

LEHIGH VALLEY, Pa. — HealthOneMed has launched a device that combines the abilities of pillboxes, reminders, dispensers and medication alerts into one.

December 17, 2010
Diabetes, inhaled corticosteroids may be linked, study finds

A link may exist between diabetes and the use of inhaled corticosteroids to treat asthma and chronic obstructive pulmonary disease, according to published reports.

NEW YORK — A link may exist between diabetes and the use of inhaled corticosteroids to treat asthma and chronic obstructive pulmonary disease, according to published reports.

HealthDay News reported that researchers analyzed data on 380,000 patients in Quebec, finding a 34% increase in the rate of new diagnoses of diabetes and progression of the disease among those who used inhalers, with greater risk among those using higher doses.

July 18, 2010
FDA: Stolen inhalers being sold at pharmacies

Some stolen inhalers for patients with asthma and chronic obstructive pulmonary disease have turned up...

SILVER SPRING, Md. Some stolen inhalers for patients with asthma and chronic obstructive pulmonary disease have turned up in pharmacies, the Food and Drug Administration warned Friday.

Two lots of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol) were stolen from a warehouse near Richmond, Va., last August, with lot numbers 9ZP2255 – NDC 0173-0696-00 and 9ZP3325 – NDC 0173-0697-00. The inhalers recently found were the first from the stolen lots to turn up in commerce, the FDA said.